UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Enhanced SMYD3 expression is essential for the growth of breast cancer cells

Cancer science, 2006-02, Vol.97 (2), p.113-118

2006

Volltextzugriff (PDF)

The Lysine 831 of Vascular Endothelial Growth Factor Receptor 1 Is a Novel Target of Methylation by SMYD3

Cancer research (Chicago, Ill.), 2007-11, Vol.67 (22), p.10759-10765

2007

Volltextzugriff (PDF)

The dynamic conformational landscape of the protein methyltransferase SETD8

eLife, 2019-05, Vol.8

2019

Volltextzugriff (PDF)

SMYD2 is highly expressed in pediatric acute lymphoblastic leukemia and constitutes a bad prognostic factor

Leukemia research, 2014-04, Vol.38 (4), p.496-502

2014

Volltextzugriff (PDF)

Plasma or Serum: Which Is Preferable for Mutation Detection in Liquid Biopsy?

Clinical chemistry (Baltimore, Md.), 2020-07, Vol.66 (7), p.946-957

2020

Volltextzugriff (PDF)

Genetic Alterations of SMYD4 in Solid Tumors Using Integrative Multi-Platform Analysis

International journal of molecular sciences, 2024-06, Vol.25 (11), p.6097

2024

Volltextzugriff (PDF)

Editorial: Epigenetic regulation and therapy resistance in cancer

Frontiers in pharmacology, 2023-01, Vol.13, p.1119073-1119073

2023

Volltextzugriff (PDF)

Therapeutic applications of CRISPR/Cas9 mediated targeted gene editing in acute lymphoblastic leukemia: current perspectives, future challenges, and clinical implications

Frontiers in pharmacology, 2023-12, Vol.14, p.1322937-1322937

2023

Volltextzugriff (PDF)

SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells

Nature cell biology, 2004-08, Vol.6 (8), p.731-740

2004

Volltextzugriff (PDF)

GLP and G9a histone methyltransferases as potential therapeutic targets for lymphoid neoplasms

Cancer cell international, 2024-07, Vol.24 (1), p.243-14, Article 243

2024

Volltextzugriff (PDF)

Tumor-Informed Approach Improved ctDNA Detection Rate in Resected Pancreatic Cancer

International journal of molecular sciences, 2022-09, Vol.23 (19), p.11521

2022

Volltextzugriff (PDF)

Structure-Based Design of a Covalent Inhibitor of the SET Domain-Containing Protein 8 (SETD8) Lysine Methyltransferase

Journal of medicinal chemistry, 2016-11, Vol.59 (21), p.9881-9889

2016

Volltextzugriff (PDF)

Structural Design, Anticancer Evaluation, and Molecular Docking of Newly Synthesized Ni(II) Complexes with ONS -Donor Dithiocarbazate Ligands

Molecules (Basel, Switzerland), 2024-06, Vol.29 (12), p.2759

2024

Volltextzugriff (PDF)

Targeting DNA Methylation as an Epigenetic Leukocyte Counting Tool

Clinical chemistry (Baltimore, Md.), 2022-05, Vol.68 (5), p.613-615

Pittella-Silva, Fabio

2022

Volltextzugriff (PDF)

Aberrant levels of SUV39H1 and SUV39H2 methyltransferase are associated with genomic instability in chronic lymphocytic leukemia

Environmental and molecular mutagenesis, 2017-12, Vol.58 (9), p.654-661

2017

Volltextzugriff (PDF)

MLL2/KMT2D and MLL3/KMT2C expression correlates with disease progression and response to imatinib mesylate in chronic myeloid leukemia

Cancer cell international, 2018-02, Vol.18 (1), p.26-10, Article 26

2018

Volltextzugriff (PDF)

Residual expression of SMYD2 and SMYD3 is associated with the acquisition of complex karyotype in chronic lymphocytic leukemia

Tumor biology, 2016-07, Vol.37 (7), p.9473-9481

2016

Volltextzugriff (PDF)

The classical photoactivated drug 8-methoxypsoralen and related compounds are effective without UV light irradiation against glioma cells

Neurochemistry international, 2016-10, Vol.99, p.33-41

2016

Volltextzugriff (PDF)

Downregulation of histone methyltransferase EHMT2 in CD4+ T-cells may protect HTLV-1-infected individuals against HAM/TSP development

Archives of virology, 2017-10, Vol.162 (10), p.3131-3136

2017

Volltextzugriff (PDF)

Dithiocarbazate ligands and their Ni(II) complexes with potential biological activity: Structural, antitumor and molecular docking study

Frontiers in molecular biosciences, 2023-03, Vol.10, p.1146820-1146820

2023

Volltextzugriff (PDF)

Long‐term in vitro treatment with telomerase inhibitor MST‐312 induces resistance by selecting long telomeres cells

Cell biochemistry and function, 2019-06, Vol.37 (4), p.273-280

2019

Volltextzugriff (PDF)

A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5′ flanking region of SMYD3 is a risk factor for human cancers

Nature genetics, 2005-10, Vol.37 (10), p.1104-1107

2005

Volltextzugriff (PDF)

Assessment of MLL methyltransferase gene expression in larynx carcinoma

Oncology reports, 2015-04, Vol.33 (4), p.2017-2022

2015

Volltextzugriff (PDF)

Effects of in vitro short- and long-term treatment with telomerase inhibitor in U-251 glioma cells

Tumor biology, 2021-12, Vol.43 (1), p.327-340

2021

Volltextzugriff (PDF)

WDRPUH, A Novel WD-Repeat—Containing Protein, Is Highly Expressed in Human Hepatocellular Carcinoma and Involved in Cell Proliferation

Neoplasia (New York, N.Y.), 2005-04, Vol.7 (4), p.348-355

2005

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(53)

Sprache

Englisch
(52)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(31)
Science & Technology
(31)
Humans
(23)
Oncology
(13)
Female
(11)
Tumors
(11)
Cancer
(10)
Histone-Lysine N-Methyltransferase - Genetics
(10)
Leukemia
(9)
Male
(9)
Middle Aged
(8)
Cell Line, Tumor
(7)
Gene Expression Regulation, Neoplastic
(7)
Mutation
(7)
Adult
(6)
Aged
(6)
Biochemistry & Molecular Biology
(6)
Dna Methylation
(6)
Epigenetics
(6)
Gene Expression
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Enhanced SMYD3 expression is essential for the growth of breast cancer cells

The Lysine 831 of Vascular Endothelial Growth Factor Receptor 1 Is a Novel Target of Methylation by SMYD3

The dynamic conformational landscape of the protein methyltransferase SETD8

SMYD2 is highly expressed in pediatric acute lymphoblastic leukemia and constitutes a bad prognostic factor

Plasma or Serum: Which Is Preferable for Mutation Detection in Liquid Biopsy?

Genetic Alterations of SMYD4 in Solid Tumors Using Integrative Multi-Platform Analysis

Editorial: Epigenetic regulation and therapy resistance in cancer

Therapeutic applications of CRISPR/Cas9 mediated targeted gene editing in acute lymphoblastic leukemia: current perspectives, future challenges, and clinical implications

SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells

GLP and G9a histone methyltransferases as potential therapeutic targets for lymphoid neoplasms

Tumor-Informed Approach Improved ctDNA Detection Rate in Resected Pancreatic Cancer

Structure-Based Design of a Covalent Inhibitor of the SET Domain-Containing Protein 8 (SETD8) Lysine Methyltransferase

Structural Design, Anticancer Evaluation, and Molecular Docking of Newly Synthesized Ni(II) Complexes with ONS -Donor Dithiocarbazate Ligands

Targeting DNA Methylation as an Epigenetic Leukocyte Counting Tool

Aberrant levels of SUV39H1 and SUV39H2 methyltransferase are associated with genomic instability in chronic lymphocytic leukemia

MLL2/KMT2D and MLL3/KMT2C expression correlates with disease progression and response to imatinib mesylate in chronic myeloid leukemia

Residual expression of SMYD2 and SMYD3 is associated with the acquisition of complex karyotype in chronic lymphocytic leukemia

The classical photoactivated drug 8-methoxypsoralen and related compounds are effective without UV light irradiation against glioma cells

Downregulation of histone methyltransferase EHMT2 in CD4+ T-cells may protect HTLV-1-infected individuals against HAM/TSP development

Dithiocarbazate ligands and their Ni(II) complexes with potential biological activity: Structural, antitumor and molecular docking study

Long‐term in vitro treatment with telomerase inhibitor MST‐312 induces resistance by selecting long telomeres cells

A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5′ flanking region of SMYD3 is a risk factor for human cancers

Assessment of MLL methyltransferase gene expression in larynx carcinoma

Effects of in vitro short- and long-term treatment with telomerase inhibitor in U-251 glioma cells

WDRPUH, A Novel WD-Repeat—Containing Protein, Is Highly Expressed in Human Hepatocellular Carcinoma and Involved in Cell Proliferation

Suchergebnisse filtern